Cliff Asness’s Vor Biopharma VOR Stock Holding History

Cliff Asness’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-560	Closed	-$11.2K	–	2879
2024 Q2	$11.2K	Buy	+560	New	+$18.1K	﹤0.01%	2584

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cliff Asness's VOR Position: Q3 2024 in Review

Cliff Asness sold out of Vor Biopharma (VOR) in Q3 2024, closing a stake of 560 shares — an estimated $11.2K sold.

Cliff Asness first reported a position in VOR in Q2 2024 and held it in 1 quarter. The position peaked at $11.2K in Q2 2024. 54 funds tracked by Wall St. Rank hold VOR as of Q3 2024.

Cliff Asness reported no remaining Vor Biopharma position as of Q3 2024 after selling out during the quarter.
Cliff Asness sold 560 Vor Biopharma shares in Q3 2024, an estimated $11.2K.
Cliff Asness first reported a position in Vor Biopharma in Q2 2024 and held it in 1 quarter.
Cliff Asness's Vor Biopharma position peaked at $11.2K in Q2 2024.
54 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.